Holen Sie sich die Stockscreener-App
47.99
0.93%
-0.45
Crispr Therapeutics Ag Aktie (CRSP) Neueste Nachrichten
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance UK
CRSP|CRISPR Therapeutics AG|Price:46.770|Chg%:+0.230 - TradingKey
BlackRock (CRSP holder) discloses 7.99M-share, 8.3% stake in CRISPR Therapeutics - Stock Titan
CRISPR Therapeutics AG (CRSP) Cash Flow - TradingKey
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Cathie Wood's Ark Bought $21.3 Million of SpaceX Stock as Shares Fell 45% From Their Record High. Wall Street's Median Price Target Is $243.81, 111.5% Above the Current Close. - The Motley Fool
CRSP|CRISPR Therapeutics AG|Price:46.540|Chg%:-0.990 - TradingKey
CRISPR Therapeutics AG (CRSP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
TradingKey - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Affinity Asset Advisors LLC Buys Shares of 150,000 CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics (CRSP) Enters Phase 1 With CTX112 In Allogeneic CAR T - Sahm
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
KBC Group NV Acquires 113,997 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics (CRSP) Short Interest & Short Float | Updated Jul 2026 - MarketBeat
CRISPR Therapeutics (CRSP) H.C. Wainwright 3rd Annual BioConnect Investor Conference 2025 summary - Quartr
CRISPR Therapeutics (CRSP) 43rd Annual J.P. Morgan Healthcare Conference 2025 summary - Quartr
Monashee Investment Management LLC Takes Position in CRISPR Therapeutics AG $CRSP - MarketBeat
Crispr Therapeutics AG (CRSP) Receives a Hold from Goldman Sachs - The Globe and Mail
CRSP: CRISPR Therapeutics AG Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating - The Motley Fool
Citizens reiterates CRISPR Therapeutics stock rating on pipeline progress - Investing.com
Citizens reiterates CRISPR Therapeutics stock rating on pipeline progress By Investing.com - Investing.com UK
US226712AA5 Bond Profile — Key Metrics - TradingView
CRISPR Therapeutics AG (CRSP) declines more than market: Some information for investors - MSN
CRISPR Therapeutics AG $CRSP Shares Sold by Amova Asset Management Americas Inc. - MarketBeat
CRISPR Therapeutics: A Catalyst-Rich 12 Months Ahead (NASDAQ:CRSP) - Seeking Alpha
CRISPR Therapeutics stock trades steady as gene-editing pipeline advances after quarterly loss narro - AD HOC NEWS
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results - ADVFN
Nwam LLC Sells 52,670 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
Has CRISPR Therapeutics (CRSP) Fallen Far Enough To Look Undervalued? - Yahoo Finance UK
Do CRISPR Therapeutics' (CRSP) EPS Projections Clarify Its Gene‑Editing Commercialisation Path? - Yahoo Finance
(CRSP) and the Role of Price-Sensitive Allocations - Stock Traders Daily
CRISPR Therapeutics (CRSP) Is Down 10.4% After EPS, Revenue Expectations Diverge From Valuation Concerns - simplywall.st
CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors - Yahoo Finance
CRISPR Therapeutics (CRSP) Slides For Six Days, Is The Stock Now Cheap? - Yahoo Finance
Is CRISPR Therapeutics (CRSP) Near Fair Value With $2.4B In Cash? - Sahm
Here's Why CRISPR Therapeutics AG (CRSP) Fell More Than Broader Market - Yahoo Finance
Citigroup Maintains CRISPR Therapeutics (CRSP) Buy Recommendation - MSN
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Canal Insurance CO Purchases New Stake in CRISPR Therapeutics AG $CRSP - MarketBeat
Crispr Therapeutics AG Slides Despite Bullish Wall Street - TipRanks
CRISPR Therapeutics AG $CRSP Position Reduced by Sumitomo Mitsui Trust Group Inc. - MarketBeat
CRSP Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
CRISPR Therapeutics AG (CRSP) stock dips while market gains: Key facts - MSN
CRISPR Therapeutics AG (CRSP) Stock Dips While Market Gains: Key Facts - Yahoo Finance
3 Reasons to Buy CRISPR Therapeutics Stock - The Motley Fool
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - AOL.com
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026? - AOL.com
CRSP Reiterated by HC Wainwright & Co. -- Price Target Maintained at $80 - GuruFocus
H.C. Wainwright reiterates CRISPR Therapeutics stock rating on label expansion By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates CRISPR Therapeutics stock rating on label expansion - Investing.com
A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics - The Motley Fool
Bank of America Securities Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP) - The Globe and Mail
2.44%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):